DEVELOPING A CELL-FREE METHYLATED DNA-BASED BIOMARKER TO DETECT NEUROENDOCRINE PROSTATE CANCER

$1,327,500FY2020Defense Health AgencyDOD

Emory University, Atlanta GA

Investigators